1. Home
  2. USA vs ANIP Comparison

USA vs ANIP Comparison

Compare USA & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USA

Liberty All-Star Equity Fund

HOLD

Current Price

$5.97

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$76.68

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USA
ANIP
Founded
N/A
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
1994
1999

Fundamental Metrics

Financial Performance
Metric
USA
ANIP
Price
$5.97
$76.68
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$107.33
AVG Volume (30 Days)
1.1M
303.5K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
N/A
3.32
Revenue
N/A
$206,547,000.00
Revenue This Year
N/A
$19.88
Revenue Next Year
N/A
$15.77
P/E Ratio
N/A
$22.86
Revenue Growth
N/A
2.47
52 Week Low
$5.64
$56.71
52 Week High
$6.96
$99.50

Technical Indicators

Market Signals
Indicator
USA
ANIP
Relative Strength Index (RSI) 43.77 45.24
Support Level $5.93 $75.20
Resistance Level $6.09 $85.12
Average True Range (ATR) 0.07 2.72
MACD 0.00 -0.04
Stochastic Oscillator 52.00 54.24

Price Performance

Historical Comparison
USA
ANIP

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: